eCLIP-qPCR Service for Targeted RBP-RNA Validation

How eCLIP-qPCR Turns Prioritized Candidates into Quantitative Evidence

The workflow begins with the biological question, not the PCR plate. Candidate regions, comparison groups, antibody suitability, and controls are defined before wet-lab work so the final enrichment values answer a specific decision: confirm, deprioritize, or redesign a candidate.

The workflow links candidate design, matched controls, wet-lab capture, and transparent qPCR reporting.

1. Project and Target Design: We review the RBP, sample type, transcript identifiers, candidate regions, existing eCLIP/CLIP evidence, and comparison groups. Early transcript-version checks prevent primers from being placed on the wrong isoform and reduce avoidable assay redesign.
2. Sample Preparation and 254 nm UV Crosslinking: Crosslinking creates covalent bonds at close RBP-RNA contacts before lysis. This permits stringent downstream washing, which makes the recovered signal more informative for contact-oriented validation.
3. Lysis and Controlled RNA Fragmentation: RNA is partially fragmented while preserving immunoprecipitable RBP-RNA complexes. Controlled fragmentation supports region-focused assays by limiting how far recovered RNA extends from the interaction area.
4. RBP Immunoprecipitation with Matched Controls: The target antibody enriches the selected RBP complex, while input and background controls measure RNA abundance and nonspecific recovery. These controls keep a low Cq value from being misread as specific binding when the transcript is simply abundant.
5. RNA Recovery and Reverse Transcription: Protein is removed and the recovered RNA is converted to cDNA. Consistent handling across IP and control arms preserves comparability at the qPCR stage.
6. Targeted qPCR and Enrichment Analysis: Prequalified assays measure selected RNA targets or regions. Control-normalized results are summarized across replicates and conditions so candidates can be ranked for downstream functional work.

At each transition, the project record captures the sample identity, antibody, candidate assay, control arm, and qPCR result. This traceability helps technical reviewers connect each reported enrichment value to the experimental decision that produced it.

Quantitative Analysis That Keeps Enrichment Interpretable

eCLIP-qPCR does not require a sequencing bioinformatics pipeline. Instead, the analysis focuses on qPCR quality, control-aware normalization, replicate consistency, and direct comparison of the predefined targets or regions that drive the study decision.

• Raw Cq Review: IP, input, and background-control values are retained so the calculation can be audited rather than presented only as a final fold value.
• Input-Aware Normalization: Input measurements account for differences in starting transcript abundance. This helps separate genuine immunoprecipitation enrichment from a transcript that is abundant in every fraction.
• Background Comparison: IgG or another planned negative control estimates nonspecific recovery. A candidate is interpreted in relation to that background, not from the IP signal alone.
• Replicate and Condition Summaries: Replicate-level values remain visible alongside group summaries, allowing researchers to see whether an apparent difference is consistent or driven by one measurement.
• Target or Region Ranking: When several candidates or amplicons are tested, normalized enrichment is displayed in a common view. This turns a list of assays into an actionable shortlist for functional validation.

No universal enrichment cutoff is imposed across all RBPs and sample types. Interpretation considers control behavior, assay efficiency, replicate pattern, target abundance, and the biological question together.

Where Targeted eCLIP-qPCR Adds the Most Value

The service is most useful after a candidate list exists. It converts discovery signals or mechanistic hypotheses into focused, quantitative evidence that can guide the next experiment.

Typical project scenarios:

• Discovery-to-Validation: An eCLIP-seq experiment has produced a ranked peak or transcript list, and the team needs a smaller set of targets confirmed with matched input and background controls before functional follow-up.
• Perturbation Confirmation: eCLIP data or prior evidence suggests that treatment, knockdown, mutation, stress, or differentiation changes RBP occupancy, and the study needs targeted measurements across the same biological groups.
• Peak-to-Region Follow-Up: A candidate eCLIP signal spans an exon, intron, untranslated region, splice junction, or structured RNA segment, and several predefined amplicons are needed to compare enrichment within that interval.
• Mechanism Prioritization: Several candidate interactions remain after discovery, and the next reporter, mutagenesis, stability, splicing, localization, or translation experiment depends on selecting the most consistently enriched targets.

Research areas supported:

When eCLIP has already produced a candidate map, eCLIP-qPCR can bring the same validation logic into diverse research fields. The assay is used to retest selected peaks or transcript regions in the relevant biological model, with sample format, antibody performance, UV access, and primer placement reviewed before the project is finalized.

Choose eCLIP-qPCR, CLIP-qPCR, RIP-qPCR, or eCLIP-seq

Method choice should follow the question you need answered. eCLIP-qPCR is a focused validation option when the RBP and target shortlist are known; it is not a substitute for an unbiased binding map.

Best for: Projects with a defined RBP, a suitable antibody, and a shortlist of RNA targets or regions, especially candidates prioritized by eCLIP-seq.

Not for: Novel target discovery, transcriptome-wide peak or motif analysis, or projects that require an exact causal nucleotide from qPCR alone. Choose eCLIP-seq for discovery; consider photoactivatable crosslinking with PAR-CLIP-seq when the design specifically calls for photoactivatable ribonucleoside incorporation and 365 nm UVA.